Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ola Svensson, MD
AZD1386AstraZeneca R&D Södertälje, Sweden
Study Chair - Richard L Leff, MD
AZD1386AstraZeneca R&D Wilmington, USA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Pleven, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Bay Roberts, Newfoundland and Labrador, Canada
- Research Site
St. John's, Newfoundland and Labrador, Canada
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
Brampton, Ontario, Canada
- Research Site
Etobicoke, Ontario, Canada
- Research Site
Hamilton, Ontario, Canada
- Research Site
Newmarket, Ontario, Canada
- Research Site
St. Catharines, Ontario, Canada
- Research Site
Charlottetown, Prince Edward Island, Canada
- Research Site
Saint Romuald, Quebec, Canada
- Research Site
Sherbrooke, Quebec, Canada
- Research Site
Helsinki, Finland
- Research Site
Hyvinkää, Finland
- Research Site
Lahti, Finland
- Research Site
Riihimäki, Finland
- Research Site
Tampere, Finland
- Research Site
Vantaa, Finland
- Research Site
Budapest, Hungary
- Research Site
Békéscsaba, Hungary
- Research Site
Debrecen, Hungary
- Research Site
Miskolc, Hungary
- Research Site
Nyíregyháza, Hungary
- Research Site
Veszprém, Hungary
- Research Site
Japan, Japan
- Research Site
Bialystok, Poland
- Research Site
Elblag, Poland
- Research Site
Gdynia, Poland
- Research Site
Krakow, Poland
- Research Site
Lublin, Poland
- Research Site
Toru, Poland
- Research Site
Warsaw, Poland
- Research Site
Brastislava, Slovakia
- Research Site
Komárno, Slovakia
- Research Site
Liptovský Hrádok, Slovakia
- Research Site
Poprad, Slovakia
- Research Site
Považská Bystrica, Slovakia
- Research Site
Rimavská Sobota, Slovakia
- Research Site
Žiar nad Hronom, Slovakia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 4 Jun 2012
- Registered enrollment
- 241
- Registry id
- NCT00878501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.